Skip to main content
. 2004 Mar 23;90(8):1555–1562. doi: 10.1038/sj.bjc.6601718

Figure 3.

Figure 3

(A) Overall survival of 88 NSCLC patients in relation to intratumoral c-Met status. (B) Overall survival of 46 patients with adenocarcinomas in relation to intratumoral c-Met status. (C) Overall survival of 53 patients with T2–4 carcinomas in relation to intratumoral c-Met status. (D) Overall survival of 88 NSCLC patients in relation between stromal HGF and intratumoral c-Met status.